These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2661003)

  • 1. Renin-positive granulated Goormaghtigh cells. Immunohistochemical and electron-microscopic studies on biopsies from patients with pseudo-Bartter syndrome.
    Christensen JA; Bohle A; Mikeler E; Taugner R
    Cell Tissue Res; 1989 Jan; 255(1):149-53. PubMed ID: 2661003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies. An immunocytochemical and electron microscopic study.
    Taugner R; Waldherr R; Seyberth HW; Erdös EG; Menard J; Schneider D
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(5):459-70. PubMed ID: 3128915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and Bartter's syndrome.
    Dunn MJ
    Kidney Int; 1981 Jan; 19(1):86-102. PubMed ID: 7012423
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative estimation of renin-containing cells in the juxtaglomerular apparatus in Bartter's and pseudo-Bartter's syndromes.
    Okada M; Lertprasertsuke N; Tsutsumi Y
    Pathol Int; 2000 Feb; 50(2):166-8. PubMed ID: 10792778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome--case report.
    Miyoshi A; Makino H; Hiramatsu M; Takahashi K; Yamane Y; Takahara J; Suzuki S; Ota Z; Ofuji T; Takehisa Y
    Acta Med Okayama; 1979 Aug; 33(4):305-14. PubMed ID: 158951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bartter's syndrome.
    Bartter FC; Gill JR; Frolich JC
    Adv Nephrol Necker Hosp; 1977; 7():191-8. PubMed ID: 96673
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
    Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
    Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental study on the hyperplasia of juxtaglomerular cells under low-dose, long-term administration of calcium chelating agents. Similar to the morphological manifestation of Bartter's syndrome.
    Yamaguchi H; Kaku H; Onodera TA; Kurokawa R; Morisada M
    Exp Toxicol Pathol; 1994 Aug; 46(3):237-41. PubMed ID: 8000245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiological aspects of the renin-angiotensin-aldosterone system].
    Oelkers W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():145-56. PubMed ID: 349923
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Bartter syndrome and the pseudo-Bartter syndrome].
    Trübestein GK; Werning C; Stadelmann O; Kuhlmann U; Stiel D; Schweikert HU; Siegenthaler W
    Munch Med Wochenschr; 1972 Apr; 114(14):635-40. PubMed ID: 4338788
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristic changes of the juxtaglomerular cells before and after treatment of pseudo-Bartter's syndrome due to furosemide abuse.
    Mizuiri S; Ozawa T; Hirata K; Takezawa K; Kawamura S
    Nephron; 1987; 46(1):23-7. PubMed ID: 3600908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six year follow-up of a child with Bartter syndrome.
    Ramanathan K; Gantt C; Grossman A
    Am J Dis Child; 1973 Aug; 126(2):230-5. PubMed ID: 4353310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of Bartter's syndrome with physiological and histological evaluation. A report of 3 cases in siblings].
    Taniguchi S; Suzuki J; Terai Y; Monma N; Satodate R; Suzuki Z
    Nihon Jinzo Gakkai Shi; 1984 Nov; 26(11):1495-508. PubMed ID: 6533374
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis of Bartter's syndrome. Functional and histologic studies.
    Fujita T; Sakaguchi H; Shibagaki M; Fukui T; Nomura M
    Am J Med; 1977 Sep; 63(3):467-74. PubMed ID: 900149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
    Iijima K; Hamahira K; Kobayashi A; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 2000 Dec; 11(12):2265-2271. PubMed ID: 11095649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome--limelight on prostaglandins.
    Vaisrub S
    JAMA; 1978 Jan; 239(2):137-8. PubMed ID: 412985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
    Abenhaim L; Kuchel O
    Union Med Can; 1979 Jun; 108(6):621-39. PubMed ID: 388782
    [No Abstract]   [Full Text] [Related]  

  • 20. On the pathogenesis of the secondary hyperaldosteronism of the Bartter syndrome.
    Nielsen I; Jacobsen JG; Olesen KH
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():301s-4. PubMed ID: 4522178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.